The Pill, migraine and stroke

Current situation 

  • Migraine is common, affecting 18 per cent and 6 per cent of the female and male US population, respectively.
  • About 80 per cent of British women use the combined oral contraception pill (COCP) at some time between the ages of 16 and 24 years.
  • Migraine is the most common type of headache in young adults, affecting as many as one in four US women by their mid-to-late 30s.
  • A potential association between migraine and risk of stroke is an important public health concern, especially in young women who use oral contraceptives.

What is the evidence?

  • A meta-analysis of 14 studies found that the use of low-dose oral contraceptives was associated with a doubling of the risk of cardiovascular disease (CVD) (J Clin Endocrinol Metab 2005; 90: 3,863-70).
  • Women who suffer from migraines with aura have an increased risk of ischaemic stroke. One study found that these women had twice the risk of CVD compared with women without a history of migraine (JAMA 2006; 296: 283-91). Interestingly, women who suffer with migraine without aura had no increased risk.
  • The results of a systematic review and meta-analysis also strongly suggest that migraine is an independent risk factor for stroke (BMJ 2005; 330: 63-4). The increased relative risks of ischaemic stroke were 1.8 in migraine without aura, 2.3 in migraine with aura and 8.7 in women who suffer with migraine who take the oral contraceptive pill.
  • A recent study showed that probable migraine with visual aura was associated with an increased risk of stroke, particularly among women without other medical conditions associated with stroke. Oral contraceptive use markedly increased the risk of probable migraine with visual aura (Stroke 2007; 38: 2,438-45).
  • A review has found increasing evidence that migraine with aura is not only a risk factor for ischaemic stroke but also for MI and other ischaemic vascular events (Curr Opin Neurol 2007; 20: 310-9).

Implications for practice

  • Prolonged exposure to low-dose oral contraceptives to those women at higher risk of CVD might significantly increase the incidence of cardiovascular outcomes and alternative contraception might be preferable.
  • Given that use of oral contraceptives is common in young women, the potential risk of stroke among women with migraine who are also users of oral contraceptives must be further investigated.
  • It might be that we should be more aggressive in our primary prevention of CVD in migraine sufferers. Dr Louise Newson is a GP in the West Midlands and author of 'Hot Topics for MRCGP and General Practitioners' PasTest 2006

Key points

  • Migraine is common in young women.
  • Migraine with aura increases the risk of stroke and CVD.
  • The COCP is contra-indicated for patients who have migraines with aura.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women and under-18s will not be offered COVID-19 vaccine

Pregnant women, children and under-18s will not be recommended for routine COVID-19...

GP training: How an audit e-portfolio log entry is assessed

GP training: How an audit e-portfolio log entry is assessed

The second of two articles on audit during GP training looks at how the quality improvement...

GP training: Writing up an audit for your e-portfolio

GP training: Writing up an audit for your e-portfolio

In the first of two articles on how to write up an audit, a typical e-portfolio entry...

UK ups order of 95% effective COVID-19 vaccine by 2m doses

UK ups order of 95% effective COVID-19 vaccine by 2m doses

The UK has increased its order of the 95% effective Moderna COVID-19 vaccine to 7m...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Which COVID-19 vaccines are lined up for roll-out on the NHS?

Which COVID-19 vaccines are lined up for roll-out on the NHS?

As GPs and their teams prepare for delivering a COVID-19 vaccination programme that...